/
URINARY TRACT INFECTIONS IN CHILDREN:AN UPDATE URINARY TRACT INFECTIONS IN CHILDREN:AN UPDATE

URINARY TRACT INFECTIONS IN CHILDREN:AN UPDATE - PowerPoint Presentation

roxanne
roxanne . @roxanne
Follow
345 views
Uploaded On 2022-06-07

URINARY TRACT INFECTIONS IN CHILDREN:AN UPDATE - PPT Presentation

DRKAUSHAMBI BASU DCHMDPEDIATRICS TUTORPEDIATRIC MEDICINE CNMCH POINTS OF DISCUSSION INTRODUCTION CLINICAL FEATURES DIAGNOSIS TREATMENT IMAGING AFTER FEBRILE UTI VUR RECURRENT UTI ANTIBIOTIC PROPHYLAXIS ID: 914007

uti urine urinary culture urine uti culture urinary prophylaxis infants children treatment renal tract dipstick method 2011 significant guidelines

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "URINARY TRACT INFECTIONS IN CHILDREN:AN ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

URINARY TRACT INFECTIONS IN CHILDREN:AN UPDATE

DR.KAUSHAMBI BASUDCH,MD(PEDIATRICS) TUTOR,PEDIATRIC MEDICINECNMCH

Slide2

POINTS OF DISCUSSION

INTRODUCTION CLINICAL FEATURESDIAGNOSISTREATMENTIMAGING AFTER FEBRILE UTIVUR RECURRENT UTIANTIBIOTIC PROPHYLAXIS

Slide3

DEFINITIONS

URINARY TRACT INFECTION(UTI):Infection of urinary tract as identified by growth of significant number of organisms of a single uropathogen in the urine, in presence of symptoms.

ASYMPTOMATIC BACTERIURIA:Significant bacteriuria in the absence of symptoms of UTI.

Do not need treatment.

SIGNIFICANT BACTERIURIA:

Colony count of more than 10^5/ml of a single species in a mid-stream clean catch urine.

Slide4

EPIDEMIOLOGY

AGE GROUPINFANCY MALE : FEMALE = 1 : 2BEYOND 1-2 YEARS MALE : FEMALE = 1 : 10

ETIOLOGYCOLONIC BACTERIA Like Escherichia coli,

Klebsiella, Proteus, Enterococcus, Pseudomonas

Other Agents :

Staphylococcus saprophyticus, group B

Streptococcus, Staphylococcus

aureus, Candida, Salmonella

Slide5

CLINICAL FEATURES OF UTI

Till 2 months

2months to 2 years

*

malodourous

urine: neither sensitive nor specific for UTI

Above 2 years

Slide6

CLASSIFYING UTIs

SIMPLE UTI

COMPLICATED UTI

Dysuria

Urgency

Frequency

Fever >39 degree

Toxicity

Recurrent

Vomiting

Dehydration

Renal angle tenderness

Slide7

PATHOGENESIS

Ascending infection : Faecal flora uncircumscribed prepuce vagina

infected urinary bladder Haematogenous spread : Bacteraemia

Septicaemia

Endocarditis

In new-borns: Mostly as a part of septicaemia

Slide8

RISK FACTORS

FEMALE GENDEROBSTRUCTIVE UROPATHY(any level)

UROLITHIASISCONSTIPATIONBOWEL-BLADDER DYSFUNCTIONPERI-URETHRAL COLONISATION

VESICO-URETERAL REFLUX

Slide9

DIAGNOSIS

ROUTINE EXAMINATION OF URINE(MICROSCOPY)URINE DIPSTICK EXAMINATION LEUKOCYTE ESTERASE & NITRITE*URINE CULTURE

*

While earlier, Dipstick tests were discouraged in children less than 2 years, recent data agree on its use

.

EXAMINE

URINE IN 30-60

mins

CULTURE

IN 4hrs.Else keep in

Fridge(4-8◦ Centigrade) for a period of 24

hrs

(max)

Slide10

NO LONGER RECOMMENDED

RECOMMENDED IN PRIMARY SETTING

2

ND

CHOICE IN HOSPITAL

CONTROVERSIAL AS PER DIFF.GUIDELINES

QUICK WEE

METHOD

1

ST

CHOICE IN HOSPITAL SETTING

CRITICALLY ILL CHILDREN

GOLD STANDARD METHOD

NOT FEASIBLE IN ROUTINE PRIMARY CARE

HOW TO COLLECT URINE:

Toilet –trained children: Mid-stream clean catch

Neonates & Infants : Suprapubic aspiration/Transurethral

catheterisation/quick wee method

Urine bag/diaper are not advised

METHODS OF COLLECTION OF URINE

Slide11

ROUTINE EXAMINATION OF URINE

SIGNIFICANT PYURIA: more than

5 leucocytes/hpf

in centrifuged urine

LEUKOCYTURIA

Fever, Glomerulonephritis, Renal stones,

presence of FB in Urinary tract.

MICROSCOPIC HEMATURIA/Excess RBC

common

not diagnostic.

Slide12

URINE DIPSTICK INTERPRETATION OF RESULT OF NITRITE AND LEUKOCYTE ESTERASE

TEST

INTERPRETATION

ACTION

NITRITE

+

LEUKOCYTE ESTERASE

+

VERY LIKELY

PERFORM URINE CULTURE

START

ANTIBIOTICS EMPIRICALLY

NITRITE

-

LEUKOCYTE ESTERASE

+

LIKELY

PERFORM URINE CULTURE

START

ANTIBIOTICS EMPIRICALLY

NITRITE

-LEUKOCYTE ESTERASE -QUITE UNLIKELYNO CULTURE NEEDEDSEARCH FOR ALTERNATE DIAGNOSISCLINICAL FU & NEW DIPSTICK TEST IF FEVER PERSISTSNITRITE +LEUKOCYTE ESTERSE -DOUBTFULPERFORM URINE CULTUREEVALUATE FOR BACTERIURIAREPEAT DIPSTICK,IF FEVER PERSISTS

*Acta

Paediatrica. 2020;109:236–247

NITRITES NEGATIVE IN FREQUENT VOIDING / BACTERIA NOT CONVERTING NITRATES TO NITRITES

Slide13

INTERPRETATION OF CULTURE RESULTS

METHOD OF COLLECTION

COLONY COUNT

SUPRAPUBIC

METHOD

ANY COUNT

TRANS-URETHRAL

CATHETER

>50,000 colonies/ml

MID

-STREAM

>100,000 colonies/ml

Low colony

counts

of a single organism also significant ,if a child is

symptomatic.

Slide14

STERILE PYURIA

( LEUKOCYTES +,CULTURE -)PARTIALLY TREATED BACTERIAL UTIVIRAL INFECTIONSRENAL TUBERCULOSIS UROLITHIASISKAWASAKI DISEASEGLOMERULONEPHRITIS

INTERSTITIAL NEPHRITISSCHISTOSOMIASIS

Slide15

BLOOD INVESTIGATIONS

CBC: LEUKOCYTOSIS,NEUTROPHILIA,ESRPRO-CALCITONIN ELEVATEDCRPRENAL FUNCTION TESTBLOOD CULTURE : BACTEREMIA

(INFANTS UPTO 3MONTHS, OBSTRUCTIVE UROPATHY)

Slide16

IMAGING

USG ABDOMEN : Limited use

Renal abscess/Acute Lobar Nephronia/

Perinephric

abscess

CT ABDOMEN

: More specific & sensitive for Acute lobar

nephronia

or Renal Abscess.

Slide17

INDICATIONS OF HOSPITALISATION

CRITICALLY ILL CHILD(SEPSIS/DEHYDRATION/VOMITING)NON-COMPLIANCE TO ORAL DRUGSFEVER PERSISTING DESPITE 3 DAYS OF APPROPRIATE ANTIBIOTIC,AS SHOWN BY SENSITIVITY PATTERN

Slide18

TREATMENT

1.EMPIRICAL ANTIBIOTICS 2.AS PER C/S REPORT

ORAL

INTRAVENOUS

Simple UTI Complicated UTI

Well-appearing Toxic look

Persisting Fever

<

3

months age

Low compliance to oral drugs

Slide19

CHOICE OF ANTIBIOTICS

ORAL INTRAVENOUS Cefixime 3

rd generation Cephalosporin Co-Amoxyclav

(Ceftriaxone/

Cefotaxime

)

FluoroQuinolones Co-

Amoxyclav

Ceftibuten

Co-

trimoxazole

: not used for treatment empirically

Nitrofurantoin : does not achieve significant renal tissue

levels

ANTIFUNGALS : Fluconazole(Oral/Intravenous) Amphotericin B(IV)

Slide20

DURATION OF THERAPY

TYPE

OF UTI

DURATION

CYSTITIS

7-10 DAYS

PYELONEPHRITIS

10-14 DAYS

UROSEPSIS

14 DAYS

RENAL ABSCESS/ACUTE LOBAR NEPHRONIA

10-14 DAYS IV ,then 2-4 WEEKS ORAL

Slide21

RESPONSE TO TREATMENT

Failure to response due to: a)presence of complicating factors b)non-sensitivity to pathogens

c)non-complianceRepeat urine culture ,if no response in 48 hrs.

No indication of Repeat Urine Culture on completion of Therapy

Slide22

IMAGING STUDIES IN CHILDREN WITH FEBRILE UTI

Slide23

IMAGING AFTER 1

ST FEBRILE UTI

GUIDELINES

ULTRASOUND

VCUG*

LATE DMSA*

ISPN 2011 <1YR

YES

YES

YES

>1YR

YES

NO

YES

>5 YRS

YES

NO

NO

NICE 2007 <6months

YES

ATYPICAL

UTIATYPICAL UTI >6monthsATYPICAL UTIRISK FACTORS/ATYPICALATYPICAL UTIAAP 2011YESNO-

ITALIAN SOCIETY ,2019

(

Acta Paediatrica. 2020;109:236–247

.)

YES

NO

YES, If

UTI Non-

E.coli

/ USG ABNORMAL

NO

YES,IF VCUG SHOWS GR IV/V VUR

*NORMAL USG

Slide24

VESICO-URETERAL REFLUX

40-50% infants and 30-50% children with UTISeverity graded by VCUG/MCU using International Study ClassificationTreatment Antibiotic Prophylaxis Endoscopic Deflux

injection Surgery

Slide25

RECURRENT UTI

2nd episode of UTIPredisposing factors: infants uncircumscribed males

females

Bladder-Bowel dysfunction(BBD)

VUR

Obstructive uropathy

30%

cases :

no identifiable factor

Slide26

PREVENTION OF RECURRENT UTI

GENERAL MEASURES: Adequate Fluid intake Low pressure voiding Double voiding Perineal hygiene

BOWEL BLADDER DYSFUNCTION TREATMENT: Treatment of constipation

Avoidance of Urinary stasis

ANTIBIOTIC PROPHYLAXIS

Slide27

ANTIBIOTIC PROPHYLAXIS

Effective against most pathogensAchieve high urinary concentration

Low Resistance

Preferred

Agents:

Co-

trimoxazole

(

to be used in infants more than 6 months)

Nitrofurantoin

(

to

be used in infants more than

3

months)

Cephalexin (

ideal in first 3 months of age)

Slide28

DURATION OF ANTIBIOTIC PROPHYLAXIS

GUIDELINES

VUR after UTI

GR I-II

VUR AFTER

UTI

GR III-V

ISPN,2011

1

yr

5

yr

Italian

Guidelines,2019

No prophylaxis

Yes,5

yrs

AAP,2011

No prophylaxis

No prophylaxis

No evidence as to prevention in scarring/permanent renal damage

Slide29

OTHER POTENTIAL OPTIONS FORPREVENTION OF RECURRENT UTI

Cranberry juiceVitamin C

Probiotics: Non-uropathogenic E.coli

Nissle

1917

Circumcision

in infants with VUR

Slide30

GAPS IN KNOWLEDGE

Role of steroids in scar preventionNitrites in absence of Leukocyturia

Slide31

TAKE HOME MESSAGES

High index of suspicion for UTIUrinary Dipstick very useful in office practiceConfirmation by Urine Culture Sensitivity Proper method of collection of urine sampleAsymptomatic Bacteriuria need not be treatedTreatment of Febrile UTIs is grossly incomplete without Imaging studies

Slide32

REFERENCES

Acta Pediatrica,2019,Updated Italian recommendations for diagnosis, treatment and follow up of first UTI in young childrenUrinary Tract Infections in children : Diagnosis, Treatment and Long-term management ,NICE Guidelines,2007

Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months

Paediatrics

 September

2011, 128 (3) 595-610

(AAP Guidelines,2011)

Revised Statement on Management of Urinary Tract

Infections, Indian

Paediatrics

2011;48: 709-717

Slide33